Medical Xpress

medicalxpress.com

#25 in Sensitive Subjects among publishers in Google Discover in Canada over the last 30 days.

Track in D2TR
CanadaLast 30 days
#25in Sensitive Subjects
44DTRSDTRS, its score in Sensitive Subjects
0.01%share of visibility
#25in Sensitive Subjects

Reach per publication

81market average is 100A typical ⁨Medical Xpress⁩ publication reaches less of Discover than the average one in this market.

Publication lifespan

1.0×the market averageIts publications stay in the feed about as long as most.
Feed positionAverage position in the feed and the number of publications are in D2TR.

Market share

Last 60 days
Share of visibilityImpressions per day4.1Kin the last 14 days
0.00%0.05%0.10%0.15%0.20%0.25%01K2K3K4K5KLast 14 daysSep 17Oct 2Oct 18Nov 2Nov 150.00%0.10%0.20%02.5K5KLast 14 daysSep 17Nov 2Impressions before Nov 2 are in D2TRUnlock the full historySign up to see daily impressions of ⁦medicalxpress.com⁩ since July 2026 and every article behind them.Sign up

Slice of the market

0.01%of all Google Discover visibility in Canada
  • Medical Xpress0.01%
  • Rest of the top 1046.6%
  • Everyone else53.4%

Top publications

Stronger cholesterol treatment shrinks more plaque in heart arteries, new clinical trial finds

Impressions3.6K
HealthIn D2TR

Experimental weight-loss drug eases painful knee osteoarthritis in two clinical trials

Impressions203
HealthIn D2TR

Blood thinner could offer a new way to treat osteoarthritis

Impressions127
In D2TR

First patient undergoes pioneering stem-cell treatment for Parkinson's

Impressions
HealthIn D2TR

In parallel mouse studies, researchers fail to replicate many reported effects of psilocybin

Impressions
HealthIn D2TR

Publications by impressions

ImpressionsPubsShare of total
Over 5M0%0%
1M to 5M0%0%
100K to 1M0%0%
10K to 100K0%0%
Under 10K100%100%

100% of its publications bring 100% of its impressions.

Where it ranks

By category

Impressions, last 14 days
HealthSensitive SubjectsNew in the top 50#25
Other categories4.1K

What it publishes

Content formats

  • News99.2%
  • Analysis0.8%

Top entities

Last 14 days
Osteoarthritis233

Who it competes with

Trends they share

Times they met
Experimental weight-loss drug retatrutide eases knee osteoarthritis in trialsagainst ⁨El Confidencial⁩1 time
Every trend it competes on, in D2TR

About ⁨Medical Xpress⁩

Main category
Sensitive Subjects
In D2TR data
since July 2026
Knowledge Graph ID
/g/11dfhf7dlx

Google profile

Open profile
394.9Ktotal followers
Last 90 days▼ 273
Facebook
181.1K
X (Twitter)
173.5K
YouTube
40.4K

Its records

Best rank
outside the top 50 August
In the top 10
in no period on record
The numbers behind the rankSign up to open the full impressions history, feed positions, authors and every article of ⁦medicalxpress.com⁩.
Sign up

Rank and share come from the D2TR publisher ranking and are rebuilt every 7 days. Impressions are shown for the last 14 days. Estimates, not Google data. D2TR is not affiliated with Google or with ⁨Medical Xpress⁩.